UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3939-3946

2012

Volltextzugriff (PDF)

Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3194-3200

2011

Volltextzugriff (PDF)

Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4372-4380

2005

Volltextzugriff (PDF)

Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4123-4128

2006

Volltextzugriff (PDF)

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2472-2479

2002

Volltextzugriff (PDF)

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1732-1740

2007

Volltextzugriff (PDF)

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Journal of clinical oncology, 2019-11, Vol.37 (31), p.JCO1901073-2824

2019

Volltextzugriff (PDF)

High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma

The Lancet (British edition), 2000-03, Vol.355 (9209), p.1071-1072

2000

Volltextzugriff (PDF)

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

European journal of cancer (1990), 2013-09, Vol.49 (13), p.2869-2876

2013

Volltextzugriff (PDF)

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era

AIDS (London), 2017-11, Vol.31 (18), p.2493-2501

2017

Volltextzugriff (PDF)

Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV

AIDS (London), 2020-03, Vol.34 (4), p.599-608

2020

Volltextzugriff (PDF)

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1133-1145

2018

Volltextzugriff (PDF)

Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study

Journal of acquired immune deficiency syndromes (1999), 2013-06, Vol.63 (2), p.249

2013

Volltextzugriff (PDF)

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

Journal of clinical oncology, 1995-04, Vol.13 (4), p.961-968

1995

Volltextzugriff (PDF)

Genomic imbalances in AIDS-related lymphomas : relation with tumoral Epstein-Barr virus status

AIDS (London), 2006-11, Vol.20 (18), p.2285-2291

2006

Volltextzugriff (PDF)

Human immunodeficiency virus–related lymphoma: relation between clinical features and histologic subtypes

The American journal of medicine, 2001-12, Vol.111 (9), p.704-711

2001

Volltextzugriff (PDF)

A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkinʼs lymphoma patients

Anti-cancer drugs, 2008-03, Vol.19 (3), p.309-315

2008

Volltextzugriff (PDF)

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy

The American journal of medicine, 1993-08, Vol.95 (2), p.188-196

1993

Volltextzugriff (PDF)

HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma

Bulletin du cancer, 2003-05, Vol.90 (5), p.419

2003

Volltextzugriff (PDF)

Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection

AIDS (London), 2000-07, Vol.14 (10), p.1457-1458

2000

Volltextzugriff (PDF)

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

The hematology journal : the official journal of the European Haematology Association, 2001, Vol.2 (6), p.378

2001

Volltextzugriff (PDF)

Carboplatin-induced acute renal failure

American journal of nephrology, 1990, Vol.10 (5), p.431

1990

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(23)
Middle Aged
(21)
Female
(20)
Male
(19)
Adult
(18)
Aged
(14)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Oncology
(13)
Treatment Outcome
(12)
Prognosis
(10)
Aged, 80 And Over
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Chemotherapy
(8)
Infectious Diseases
(8)
Prospective Studies
(8)
Adolescent
(7)
Survival Analysis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants

Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era

Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV

HCV or HBV coinfection and lymphoma risk in people living with HIV

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial

Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

Genomic imbalances in AIDS-related lymphomas : relation with tumoral Epstein-Barr virus status

Human immunodeficiency virus–related lymphoma: relation between clinical features and histologic subtypes

A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkinʼs lymphoma patients

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy

HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma

Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

Carboplatin-induced acute renal failure

Aktive Filter

Suchergebnisse filtern